209 related articles for article (PubMed ID: 31876704)
21. Topical betamethasone for prevention of radiation dermatitis.
Omidvari S; Saboori H; Mohammadianpanah M; Mosalaei A; Ahmadloo N; Mosleh-Shirazi MA; Jowkar F; Namaz S
Indian J Dermatol Venereol Leprol; 2007; 73(3):209. PubMed ID: 17561562
[TBL] [Abstract][Full Text] [Related]
22. A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial.
Robijns J; Van Bever L; Hermans S; Claes M; Lodewijckx J; Lenaerts M; Tuts L; Vandaele E; Vinken E; Noé L; Verboven K; Maes A; Van de Velde AS; Bulens P; Bulens P; Van den Bergh L; Mebis J
Support Care Cancer; 2023 Oct; 31(12):625. PubMed ID: 37819539
[TBL] [Abstract][Full Text] [Related]
23. 3M Cavilon No-Sting Barrier Film or topical corticosteroid (mometasone furoate) for protection against radiation dermatitis: A clinical trial.
Shaw SZ; Nien HH; Wu CJ; Lui LT; Su JF; Lang CH
J Formos Med Assoc; 2015 May; 114(5):407-14. PubMed ID: 23685085
[TBL] [Abstract][Full Text] [Related]
24. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial.
Hindley A; Zain Z; Wood L; Whitehead A; Sanneh A; Barber D; Hornsby R
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):748-55. PubMed ID: 25585779
[TBL] [Abstract][Full Text] [Related]
25. The comparison of acute toxicity in 2 treatment courses: Three-weekly and weekly cisplatin treatment administered with radiotherapy in patients with head and neck squamous cell carcinoma.
Mackiewicz J; Rybarczyk-Kasiuchnicz A; Łasińska I; Mazur-Roszak M; Świniuch D; Michalak M; Kaźmierska J; Studniarek A; Krokowicz Ł; Bajon T
Medicine (Baltimore); 2017 Dec; 96(51):e9151. PubMed ID: 29390445
[TBL] [Abstract][Full Text] [Related]
26. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
27. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
28. A scoring system predicting acute radiation dermatitis in patients with head and neck cancer treated with intensity-modulated radiotherapy.
Kawamura M; Yoshimura M; Asada H; Nakamura M; Matsuo Y; Mizowaki T
Radiat Oncol; 2019 Jan; 14(1):14. PubMed ID: 30665451
[TBL] [Abstract][Full Text] [Related]
29. The effect of Mepitel Film on acute radiation-induced skin reactions in head and neck cancer patients: a feasibility study.
Wooding H; Yan J; Yuan L; Chyou TY; Gao S; Ward I; Herst PM
Br J Radiol; 2018 Jan; 91(1081):20170298. PubMed ID: 29072852
[TBL] [Abstract][Full Text] [Related]
30. Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance]).
Sio TT; Atherton PJ; Birckhead BJ; Schwartz DJ; Sloan JA; Seisler DK; Martenson JA; Loprinzi CL; Griffin PC; Morton RF; Anders JC; Stoffel TJ; Haselow RE; Mowat RB; Wittich MA; Bearden JD; Miller RC
Support Care Cancer; 2016 Sep; 24(9):3847-55. PubMed ID: 27075674
[TBL] [Abstract][Full Text] [Related]
31. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
[TBL] [Abstract][Full Text] [Related]
32. Prospective randomized controlled trial to compare 3-dimensional conformal radiotherapy to intensity-modulated radiotherapy in head and neck squamous cell carcinoma: Long-term results.
Ghosh-Laskar S; Yathiraj PH; Dutta D; Rangarajan V; Purandare N; Gupta T; Budrukkar A; Murthy V; Kannan S; Agarwal JP
Head Neck; 2016 Apr; 38 Suppl 1():E1481-7. PubMed ID: 26561342
[TBL] [Abstract][Full Text] [Related]
33. Phase III Trial of an emulsion containing trolamine for the prevention of radiation dermatitis in patients with advanced squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Trial 99-13.
Elliott EA; Wright JR; Swann RS; Nguyen-Tân F; Takita C; Bucci MK; Garden AS; Kim H; Hug EB; Ryu J; Greenberg M; Saxton JP; Ang K; Berk L;
J Clin Oncol; 2006 May; 24(13):2092-7. PubMed ID: 16648511
[TBL] [Abstract][Full Text] [Related]
34. Topical use of Jiawei Simiao Yongan Gao to prevent radiodermatitis in patients with head and neck cancer: A retrospective cohort study.
Song F; Liao Z; Li T; Kang N; Li Z; Fan S; Liu F
Medicine (Baltimore); 2020 Nov; 99(48):e23318. PubMed ID: 33235092
[TBL] [Abstract][Full Text] [Related]
35. Topical Betamethasone Valerate As a Prophylactic Agent to Prevent Acute Radiation Dermatitis in Head and Neck Malignancies: A Randomized, Open-Label, Phase 3 Trial.
Menon A; Prem SS; Kumari R
Int J Radiat Oncol Biol Phys; 2021 Jan; 109(1):151-160. PubMed ID: 32853709
[TBL] [Abstract][Full Text] [Related]
36. Phase 2 study of silver leaf dressing for treatment of radiation-induced dermatitis in patients receiving radiotherapy to the head and neck.
Vavassis P; Gelinas M; Chabot Tr J; Nguyen-Tân PF
J Otolaryngol Head Neck Surg; 2008 Feb; 37(1):124-9. PubMed ID: 18479639
[TBL] [Abstract][Full Text] [Related]
37. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
38. Normal Tissue Complication Probability Model for Acute Radiation Dermatitis in Patients With Head and Neck Cancer Treated With Carbon Ion Radiation Therapy.
Li Y; Sakai M; Tsunoda A; Kubo N; Kitada Y; Kubota Y; Matsumura A; Zhou Y; Ohno T
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):675-684. PubMed ID: 35278673
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.
Gujral MS; Patnaik PM; Kaul R; Parikh HK; Conradt C; Tamhankar CP; Daftary GV
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S23-8. PubMed ID: 11561868
[TBL] [Abstract][Full Text] [Related]
40. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
